Publications by authors named "K Siirila-Waris"
Article Synopsis
- * Among 1,152 patients studied, those with normotensive acute heart failure exhibited significantly higher levels of hemodynamic stress and heart cell injury markers compared to those who were hypertensive.
- * The findings indicated that normotensive patients had a higher risk of mortality, particularly if their biomarker levels were elevated, which was confirmed in a separate cohort of 324 patients.
Aims: Data on the prognostic role of left and right bundle branch blocks (LBBB and RBBB), and nonspecific intraventricular conduction delay (IVCD; QRS ≥ 110 ms, no BBB) in acute heart failure (AHF) are controversial. Our aim was to investigate electrocardiographic predictors of long-term survival in patients with AHF and acutely decompensated chronic heart failure (ADCHF).
Methods And Results: We analysed the admission electrocardiogram of 982 patients from a multicenter European cohort of AHF with 3.
Background: Acute coronary syndromes (ACS) may precipitate up to a third of acute heart failure (AHF) cases. We assessed the characteristics, initial management, and survival of AHF patients with (ACS-AHF) and without (nACS-AHF) concomitant ACS.
Methods And Results: Data from 620 AHF patients were analyzed in a prospective multicenter study.
Management of acute heart failure and the effect of systolic blood pressure on the use of intravenous therapies.
Eur Heart J Acute Cardiovasc Care
September 2013
Aims: To examine the use of the treatments for acute heart failure (AHF) recommended by ESC guidelines in different clinical presentations and blood pressure groups.
Methods: The use of intravenous diuretics, nitrates, opioids, inotropes, and vasopressors as well as non-invasive ventilation (NIV) was analysed in 620 patients hospitalized due to AHF. The relation between AHF therapies and clinical presentation, especially systolic blood pressure (SBP) on admission, was also assessed.
Context: Cardiorenal biomarkers (CBs) predict outcome in acute heart failure (AHF).
Objective: To evaluate CBs in early follow-up prognostication.
Methods: In 124 AHF patients, levels of CystatinC, NT-proBNP and TroponinI measured five weeks from admission (W5) and relative change from day 2 (D2) were assessed for 6-month prognosis (mortality/HF hospitalization).